JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future ProspectsShubhasree Banerjee, Daniella M. Schwartz|Drugs|2017Cited by 1.2k
Multiplexed Functional Assessment of Genetic Variants in CARD11Iana Meitlis, Richard G. James, Nathan D. Camp et al.|The American Journal of Human Genetics|2020Cited by 81
Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory SyndromeHratch Baghdassarian, Lori Broderick, Sarah A. Blackstone et al.|New England Journal of Medicine|2023Cited by 78